Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022

BUY
$224.85 - $279.04 $224,850 - $279,040
1,000 Added 19.23%
6,200 $1.71 Million
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $221,600 - $272,710
-1,000 Reduced 16.13%
5,200 $1.2 Million
Q2 2017

Aug 10, 2017

BUY
N/A
6,200
6,200 $510,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track R.M.Sincerbeaux Capital Management LLC Portfolio

Follow R.M.Sincerbeaux Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of R.M.Sincerbeaux Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on R.M.Sincerbeaux Capital Management LLC with notifications on news.